A citation-based method for searching scientific literature

Brent T Mausbach, Richard B Schwab, Scott A Irwin. Breast Cancer Res Treat 2015
Times Cited: 51







List of co-cited articles
224 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer.
Dawn L Hershman, Theresa Shao, Lawrence H Kushi, Donna Buono, Wei Yann Tsai, Louis Fehrenbacher, Marilyn Kwan, Scarlett Lin Gomez, Alfred I Neugut. Breast Cancer Res Treat 2011
474
19

Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review.
Caitlin C Murphy, L Kay Bartholomew, Melissa Y Carpentier, Shirley M Bluethmann, Sally W Vernon. Breast Cancer Res Treat 2012
347
19

Depression and cancer mortality: a meta-analysis.
M Pinquart, P R Duberstein. Psychol Med 2010
502
19

Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments.
A M H Krebber, L M Buffart, G Kleijn, I C Riepma, R de Bree, C R Leemans, A Becker, J Brug, A van Straten, P Cuijpers,[...]. Psychooncology 2014
355
17

Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies.
Alex J Mitchell, Melissa Chan, Henna Bhatti, Marie Halton, Luigi Grassi, Christoffer Johansen, Nicholas Meader. Lancet Oncol 2011
17


Influence of patient and treatment factors on adherence to adjuvant endocrine therapy in breast cancer.
Catherine M Bender, Amanda L Gentry, Adam M Brufsky, Frances E Casillo, Susan M Cohen, Meredith M Dailey, Heidi S Donovan, Jacqueline Dunbar-Jacob, Rachel C Jankowitz, Margaret Q Rosenzweig,[...]. Oncol Nurs Forum 2014
72
15



Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Christina Davies, Hongchao Pan, Jon Godwin, Richard Gray, Rodrigo Arriagada, Vinod Raina, Mirta Abraham, Victor Hugo Medeiros Alencar, Atef Badran, Xavier Bonfill,[...]. Lancet 2013
11

Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update.
Harold J Burstein, Sarah Temin, Holly Anderson, Thomas A Buchholz, Nancy E Davidson, Karen E Gelmon, Sharon H Giordano, Clifford A Hudis, Diana Rowden, Alexander J Solky,[...]. J Clin Oncol 2014
461
11

Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age.
Wolfgang Linden, Andrea Vodermaier, Regina Mackenzie, Duncan Greig. J Affect Disord 2012
461
11

Antidepressants for the treatment of depression in people with cancer.
Giovanni Ostuzzi, Faith Matcham, Sarah Dauchy, Corrado Barbui, Matthew Hotopf. Cochrane Database Syst Rev 2018
36
16

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.
C Davies, J Godwin, R Gray, M Clarke, D Cutter, S Darby, P McGale, H C Pan, C Taylor, Y C Wang,[...]. Lancet 2011
9

Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality.
B Makubate, P T Donnan, J A Dewar, A M Thompson, C McCowan. Br J Cancer 2013
154
9

Suicide and cardiovascular death after a cancer diagnosis.
Fang Fang, Katja Fall, Murray A Mittleman, Pär Sparén, Weimin Ye, Hans-Olov Adami, Unnur Valdimarsdóttir. N Engl J Med 2012
235
9

Depression and anxiety in women with early breast cancer: five year observational cohort study.
Caroline Burgess, Victoria Cornelius, Sharon Love, Jill Graham, Michael Richards, Amanda Ramirez. BMJ 2005
709
9

Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients.
Dawn L Hershman, Lawrence H Kushi, Theresa Shao, Donna Buono, Aaron Kershenbaum, Wei-Yann Tsai, Louis Fehrenbacher, Scarlett Lin Gomez, Sunita Miles, Alfred I Neugut. J Clin Oncol 2010
506
9

Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: a cross-sectional analysis of routinely collected clinical data.
Jane Walker, Christian Holm Hansen, Paul Martin, Stefan Symeonides, Ravi Ramessur, Gordon Murray, Michael Sharpe. Lancet Psychiatry 2014
158
9



Psychological interventions for women with non-metastatic breast cancer.
Ghufran A Jassim, David L Whitford, Anne Hickey, Ben Carter. Cochrane Database Syst Rev 2015
69
7

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.
R Peto, C Davies, J Godwin, R Gray, H C Pan, M Clarke, D Cutter, S Darby, P McGale, C Taylor,[...]. Lancet 2012
7

Adherence to tamoxifen over the five-year course.
Timothy L Lash, Matthew P Fox, Jennifer L Westrup, Aliza K Fink, Rebecca A Silliman. Breast Cancer Res Treat 2006
244
7

Adherence to endocrine therapy in breast cancer adjuvant and prevention settings.
Rowan T Chlebowski, Jisang Kim, Reina Haque. Cancer Prev Res (Phila) 2014
97
7

Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer.
Oscar Arrieta, Laura P Angulo, Carolina Núñez-Valencia, Yuzmiren Dorantes-Gallareta, Eleazar O Macedo, Dulce Martínez-López, Salvador Alvarado, José-Francisco Corona-Cruz, Luis F Oñate-Ocaña. Ann Surg Oncol 2013
142
7

Prevalence of depression in adults with cancer: a systematic review.
J Walker, C Holm Hansen, P Martin, A Sawhney, P Thekkumpurath, C Beale, S Symeonides, L Wall, G Murray, M Sharpe. Ann Oncol 2013
126
7

Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative review.
Leah K Lambert, Lynda G Balneaves, A Fuchsia Howard, Carolyn C Gotay. Breast Cancer Res Treat 2018
48
8



The hospital anxiety and depression scale.
A S Zigmond, R P Snaith. Acta Psychiatr Scand 1983
5

Adherence to hormone therapy among women with breast cancer.
Claudia Brito, Margareth Crisóstomo Portela, Mauricio Teixeira Leite de Vasconcellos. BMC Cancer 2014
34
8


Short-term effectiveness of a web-based tailored intervention for cancer survivors on quality of life, anxiety, depression, and fatigue: randomized controlled trial.
Roy A Willems, Catherine A W Bolman, Ilse Mesters, Iris M Kanera, Audrey A J M Beaulen, Lilian Lechner. Psychooncology 2017
61
5

Psychological intervention targeting distress for cancer patients: a meta-analytic study investigating uptake and adherence.
Rachel Brebach, Louise Sharpe, Daniel S J Costa, Paul Rhodes, Phyllis Butow. Psychooncology 2016
58
5

Adherence to medication.
Lars Osterberg, Terrence Blaschke. N Engl J Med 2005
5

The PHQ-9: validity of a brief depression severity measure.
K Kroenke, R L Spitzer, J B Williams. J Gen Intern Med 2001
5

Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis.
Janine Giese-Davis, Kate Collie, Kate M S Rancourt, Eric Neri, Helena C Kraemer, David Spiegel. J Clin Oncol 2011
266
5

Supportive-expressive group therapy for women with metastatic breast cancer: survival and psychosocial outcome from a randomized controlled trial.
David W Kissane, Brenda Grabsch, David M Clarke, Graeme C Smith, Anthony W Love, Sidney Bloch, Raymond D Snyder, Yuelin Li. Psychooncology 2007
193
5

Effect of dignity therapy on distress and end-of-life experience in terminally ill patients: a randomised controlled trial.
Harvey Max Chochinov, Linda J Kristjanson, William Breitbart, Susan McClement, Thomas F Hack, Tom Hassard, Mike Harlos. Lancet Oncol 2011
323
5

A brief measure for assessing generalized anxiety disorder: the GAD-7.
Robert L Spitzer, Kurt Kroenke, Janet B W Williams, Bernd Löwe. Arch Intern Med 2006
5

Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: systematic review and meta-analysis.
Hermann Faller, Michael Schuler, Matthias Richard, Ulrike Heckl, Joachim Weis, Roland Küffner. J Clin Oncol 2013
368
5

Patient centered experiences in breast cancer: predicting long-term adherence to tamoxifen use.
Katherine L Kahn, Eric C Schneider, Jennifer L Malin, John L Adams, Arnold M Epstein. Med Care 2007
179
5


Barriers to and facilitative processes of endocrine therapy adherence among women with breast cancer.
Emma E Bright, Keith J Petrie, Ann H Partridge, Annette L Stanton. Breast Cancer Res Treat 2016
24
12

Persistence in patients with breast cancer treated with tamoxifen or aromatase inhibitors: a retrospective database analysis.
P Hadji, V Ziller, J Kyvernitakis, M Bauer, G Haas, N Schmidt, K Kostev. Breast Cancer Res Treat 2013
63
5

Prevalence of menopausal symptoms and their influence on adherence in women with breast cancer.
I Kyvernitakis, V Ziller, O Hars, M Bauer, M Kalder, P Hadji. Climacteric 2014
39
7

The validity of the Hospital Anxiety and Depression Scale. An updated literature review.
Ingvar Bjelland, Alv A Dahl, Tone Tangen Haug, Dag Neckelmann. J Psychosom Res 2002
5

Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer.
V Ziller, M Kalder, U-S Albert, W Holzhauer, M Ziller, U Wagner, P Hadji. Ann Oncol 2009
195
5



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.